Skip to main content
. Author manuscript; available in PMC: 2020 May 22.
Published in final edited form as: Pharmacol Ther. 2012 Oct 18;137(2):216–224. doi: 10.1016/j.pharmthera.2012.10.004

Fig. 2.

Fig. 2.

Response of 26 year old Ewing sarcoma patient treated with IGF1R antibody R1507. CT scan showing response to treatment of lung metastasis at baseline (on left) and following 6 weeks of treatment with 9 mg/kg/week of R1507. The yellow arrows highlight specific metastatic lesions.